Newly reported from Austria: Integration of MRI Screening Beneficial for Prostate Cancer

Integrating magnetic resonance imaging (MRI) into prostate cancer (PCa) screening is associated with a reduction in unnecessary biopsies and overdiagnosis of insignificant disease, according to a review published online April 5 in JAMA Oncology to coincide with the 39th Annual European Association of Urology Congress, held from April 5 to 8 in Paris.

Tamás Fazekas, M.D., from the Medical University of Vienna, and colleagues conducted a systematic review to compare the diagnostic value of screening pathways incorporating MRI with targeted biopsy and prostate-specific antigen (PSA)-based screening with systematic biopsy strategies.

Source: Advances and More licensed by HealthDay